1. Direct K-Ras Inhibitors to Treat Cancers: Progress, New Insights, and Approaches to Treat Resistance
   Ruth Nussinov et al, 2024, Annual Review of Pharmacology and Toxicology CrossRef
2. ALDOA coordinates PDE3A through the β-catenin/ID3 axis to stimulate cancer metastasis and M2 polarization in lung cancer with EGFR mutations
   Chia-Ying Yeh et al, 2024, Biochemical and Biophysical Research Communications CrossRef
3. Targeting metabolic adaptive responses induced by glucose starvation inhibits cell proliferation and enhances cell death in osimertinib-resistant non-small cell lung cancer (NSCLC) cell lines
   Kamal Eltayeb et al, 2024, Biochemical Pharmacology CrossRef
4. DUSP1 Promotes Osimertinib Drug-Tolerant Persistence by Inhibiting MAPK/ERK Signaling in Non-small Cell Lung Cancer
   Wenjuan He et al, 2024, Molecular Biotechnology CrossRef
5. SLC7A11, a potential immunotherapeutic target in lung adenocarcinoma
   Qingqing Shan et al, 2023, Scientific Reports CrossRef
6. T6496 targeting EGFR mediated by T790M or C797S mutant: machine learning, virtual screening and bioactivity evaluation study
   Linxiao Wang et al, 2024, Journal of Biomolecular Structure and Dynamics CrossRef
7. Computer-Assisted Drug Discovery of a Novel Theobromine Derivative as an EGFR Protein-Targeted Apoptosis Inducer
   Ibrahim H Eissa et al, 2023, Evolutionary Bioinformatics CrossRef
8. Comparison between Three Different Techniques for the Detection of EGFR Mutations in Liquid Biopsies of Patients with Advanced Stage Lung Adenocarcinoma
   Milena Casula et al, 2023, International Journal of Molecular Sciences CrossRef
9. Efficacy of Definitive Radiotherapy for Patients with Clinical Stage IIIB or IIIC Lung Adenocarcinoma and Epidermal Growth Factor Receptor (EGFR) Mutations Treated Using First- or Second-Generation EGFR Tyrosine Kinase Inhibitors
   Chih-Yen Tu et al, 2024, Canadian Respiratory Journal CrossRef
10. The pathological significance and potential mechanism of ARHGEF6 in lung adenocarcinoma
    Tiaozhan Zheng et al, 2023, Computers in Biology and Medicine CrossRef
11. Anticancer effect of covalent purine-containing EGFR TKI, ZZC4 and its mechanism of action through network pharmacology
    Mawusse K.I. Attiogbe et al, 2024, Life Sciences CrossRef
12. Multisequence MRI-based radiomics nomogram for early prediction of osimertinib resistance in patients with non-small cell lung cancer brain metastases
    Xinna Lv et al, 2023, European Journal of Radiology Open CrossRef
13. Doxazosin inhibits vasculogenic mimicry in human non‑small cell lung cancer through inhibition of the VEGF‑A/VE‑cadherin/mTOR/MMP pathway
    Jui-Ling Hsu et al, 2024, Oncology Letters CrossRef
14. GW4869 Can Inhibit Epithelial-Mesenchymal Transition and Extracellular HSP90α in Gefitinib-Sensitive NSCLC Cells
    Xuan Wan et al, 2023, OncoTargets and Therapy CrossRef
15. Regulation of Autophagy via Carbohydrate and Lipid Metabolism in Cancer
    Javad Alizadeh et al, 2023, Cancers CrossRef
16. Patient-derived organoids of lung cancer based on organoids-on-a-chip: enhancing clinical and translational applications
    Xiao Zeng et al, 2023, Frontiers in Bioengineering and Biotechnology CrossRef
17. Advances in genetic profile and therapeutic strategy of pulmonary large cell neuroendocrine carcinoma
    Siyu Zhu et al, 2024, Frontiers in Medicine CrossRef
18. Advances in erlotinib delivery systems: Addressing challenges and exploring opportunities in EGFR-targeted cancer therapies
    Mehrab Pourmadadi et al, 2024, Inorganic Chemistry Communications CrossRef